300+ investors in your industry, stage, and region Get
Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Fashion
Social
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Brazil
Africa
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Sweden
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Nepal
Malawi
Madagascar
Russian Federation
Mexico
Sudan
Pakistan
Tajikistan
Zambia
Oman
Romania
Poland
Puerto Rico
Guernsey
Cameroon
Colombia
Armenia
China
Costa Rica
Kuwait
Czech Republic
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Morocco
Paraguay
Moldova
Seychelles
Botswana
South Africa
France
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Angola
Europe
Cyprus
Spain
Qatar
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Hivemind Capital Partners, VC Fund

Hivemind Capital Partners

VC Fund

New York, United States

Hivemind Capital Partners is a blockchain-focused investment business. It specializes in the fields of cryptocurrency, blockchain, and financial services. Hivemind Capital Partners was founded in 2021 and headquartered in New York, United States.

Total investments:
45
Last investment:
Lead investor:
49%
Fund size:
$60M
Last fund:

Last updated:

Industries Hivemind Capital Partners invests in

Financial ServicesBlockchainBitcoinFinTechSoftware

Stages Hivemind Capital Partners invests in

SeedPre-SeedPost-IPO EquityVenture - Series UnknownSeries A

Countries Hivemind Capital Partners invests in

United StatesUnited KingdomCanadaHong KongNigeria

Round sizes

Seed $2.1M–$7MPre-Seed $1M–$2.4MPost-IPO Equity $100M–$558M

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

Round size

Seed
$2.1M–$7M
Pre-Seed
$1M–$2.4M
Post-IPO Equity
$100M–$558M

Investment Focus

Industry

  • Financial Services 12 (27%)
  • Blockchain 11 (24%)
  • Bitcoin 10 (22%)
  • FinTech 7 (16%)
  • Software 5 (11%)
See all 62 industries →

Stage

  • Seed 20 (44%)
  • Pre-Seed 5 (11%)
  • Post-IPO Equity 5 (11%)
  • Venture - Series Unknown 5 (11%)
  • Series A 3 (7%)
See all 9 stages →

Country

  • United States 24 (53%)
  • United Kingdom 3 (7%)
  • Canada 2 (4%)
  • Hong Kong 2 (4%)
  • Nigeria 1 (2%)
See all 7 countries →

Team

NameTitleInvestmentsLinksEmail
Matt Zhang
Matt Zhang Founder and Managing Partner
Founder and Managing Partner Total investments: 5
Find email
Sam Peurifoy
Sam Peurifoy Partner
Partner Total investments: 1
Find email

Investments

CompanyDescriptionRoundLinks
Daya Labs operates a unified financial infrastructure that integrates stablecoin rails, real-time foreign exchange, and modern treasury systems. The platform enables enterprise clients to process global business payouts, manage multi-currency balances, and settle international cross-border transactions using local fiat and digital currencies. $2.4M / Pre-Seed / Jun 24, 2026
RDC RDC
Receipts Depositary Corporation (RDC) provides a platform for investing in digital and alternative assets. The company leverages the Depositary Receipt (DR) structure to simplify the investment process. RDC does not operate or hold assets directly but facilitates investments through its platform. The company focuses on making it easier forinvestors to access a variety of asset classes, including cryptocurrencies and other digital assets. $7M / Seed / Jun 16, 2026
Upexi is a multi-faceted brand owner that focuses on direct-to-consumer and Amazon brands. The company pursues organic growth for its present brands while operating in sectors with high growth trends. The objective of Upexi is to keep gathering consumer information and develop a sizable client database across all markets we serve. $36M / Post-IPO Debt / Jan 13, 2026
Zynk is a fintech company that offers global payments and liquidity infrastructure. $5M / Seed / Nov 04, 2025
AgriFORCE develops technologies and solutions to improve sustainable farming. It provides digital tools to create growing systems, indoor hydroponics, and micropropagation. AgriFORCE is based in Vancouver, Canada. $214.4M / Post-IPO Equity / Oct 27, 2025
Fleak is a serverless API builder tailored for creating AI data workflows effortlessly. It enables users to quickly develop and deploy API backends with a single click. Leveraging a low-code workflow builder, Fleak simplifies request payload manipulation using SQL, integrates seamlessly with LLM or embedding models, and supports invoking AWS Lambdafunctions. Fleak excels in handling parallelization and concurrency, automatically optimizing performance for high throughput across all nodes. This ensures scalable and reliable API deployment without requiring users to manage multithreading or load balancing. Outputs can be delivered directly via synchronous HTTP responses or forwarded to third-party data storage systems like Snowflake and Pinecone, making Fleak production-ready for enterprise applications. $6M / Seed / Oct 01, 2025
VERB Technology Company is a software-as-a-Service, or SaaS, applications platform developer. Its platform is comprised of sales enablement business software products marketed on a subscription basis. The applications are available in both mobile and desktop versions. It includes verbCRM, Customer Relationship Management application, verbLEARN,Learning Management System application, and verbLIVE, its Live Broadcast Video Webinar application. $558M / Post-IPO Equity / Aug 04, 2025
RD Wallet is a licenced Stored Value Facility in Hong Kong. It is the first business-focused, multiple-currency mobile wallet. RD Wallet offers deposits, local and cross-border payments and foreign exchange services for businesses. $40M / Series A / Jul 30, 2025
Fundamental Global is a reinsurance and investment management holding company focused on opportunistic collateralized and loss capped reinsurance, while allocating capital in partnership with Fundamental Global® to SPAC and SPAC sponsor-related businesses. $200M / Post-IPO Equity / Jul 30, 2025
MEI Pharma, Inc. (Nasdaq: MEIP) is a San Diego-based oncology company focused on the clinical development of novel therapies for cancer. The Company’s clinical development pipeline includes lead drug candidate Pracinostat, a potential best-in-class, oral histone deacetylase (HDAC) inhibitor. Pracinostat has been tested in more than 150 patients inmultiple Phase I and exploratory Phase II clinical trials, including advanced hematologic malignancies such as myelodysplastic syndrome, acute myeloid leukemia and myelofibrosis. The Company expects to initiate a randomized Phase II trial of Pracinostat in combination with standard-of-care in at least one hematologic malignancy toward the middle of 2013. In addition, MEI Pharma is developing two drug candidates derived from its isoflavone-based technology platform, ME-143 and ME-344. Results from a Phase I trial of intravenous ME-143 in heavily treated patients with solid refractory tumors were presented at the American Society of Clinical Oncology Annual Meeting in June 2012. A Phase I clinical trial of intravenous ME-344 in patients with solid refractory tumors is ongoing. $100M / Post-IPO Equity / Jul 18, 2025
See all 45 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Fashion
Social
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Brazil
Africa
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Sweden
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Nepal
Malawi
Madagascar
Russian Federation
Mexico
Sudan
Pakistan
Tajikistan
Zambia
Oman
Romania
Poland
Puerto Rico
Guernsey
Cameroon
Colombia
Armenia
China
Costa Rica
Kuwait
Czech Republic
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Morocco
Paraguay
Moldova
Seychelles
Botswana
South Africa
France
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Angola
Europe
Cyprus
Spain
Qatar
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Hivemind Capital Partners invest in?

Hivemind Capital Partners invests primarily in Financial Services, Blockchain and Bitcoin startups, most often at Seed and Pre-Seed stage. Most of the 45 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What round sizes does Hivemind Capital Partners invest in?

Hivemind Capital Partners typically joins rounds of $2.1M–$7M at Seed, $1M–$2.4M at Pre-Seed and $100M–$558M at Post-IPO Equity. These are whole funding-round sizes, not Hivemind Capital Partners's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Hivemind Capital Partners took part in.

How do I contact Hivemind Capital Partners?

Public channels for Hivemind Capital Partners include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Hivemind Capital Partners?

The team at Hivemind Capital Partners includes Matt Zhang (Founder and Managing Partner) and Sam Peurifoy (Partner). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Hivemind Capital Partners Hivemind Capital Partners Find emails